Full text
Earnings transcript
Read the complete earnings call transcript.
CLVT
CLVT
Clarivate Plc
$2.38
-0.06
(-2.46%)
| Exchange: | NYSE |
| Market Cap: | 1.521B |
| Shares Outstanding: | 305.25M |
Delayed data
About The Company
| Sector: | Technology | |||||
| Industry: | Information Technology Services | |||||
| CEO: | Matitiahu Shem Tov | |||||
| Full Time Employees: | 12000 | |||||
| Address: |
| |||||
| Website: | https://www.clarivate.com |
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company’s portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate’s diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 2,628,800 | 2,556,700 | 2,455,200 |
| Gross Profit | 1,722,400 | 1,687,500 | 1,621,600 |
| EBITDA | -10,500 | 456,600 | 828,699.999 |
| Operating Income | -734,700 | -275,600 | 71,500 |
| Net Income | -911,200 | -636,700 | -201,100 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 12,706,800 | 11,490,200 | 11,069,400 |
| Total Liabilities | 6,714,500 | 6,351,200 | 6,226,500 |
| Total Stockholders Equity | 5,992,300 | 5,139,000 | 4,842,900 |
| Total Debt | 4,808,700 | 4,592,500 | 4,479,300 |
| Cash and Cash Equivalents | 370,700 | 295,200 | 329,200 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 744,200 | 744,200 | 628,500 |
| Capital Expenditure | -242,500 | -242,500 | 0 |
| Free Cash Flow | 501,700 | 501,700 | 628,500 |
| Net Income | -911,200 | -911,200 | 0 |
| Net Change in Cash | 13,900 | 13,900 | 0 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 2,475,124.684 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 2,479,183.713 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 2,477,154.199 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | -101,322.963 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | -101,157.072 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | -101,240.018 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 620,008.305 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 631,191.818 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 625,600.062 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 728,471.753 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 729,666.395 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 729,069.074 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0.930 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0.940 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0.920 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 6 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Revenue Performance: CLVT has demonstrated consistent revenue growth as reported in recent income statements, reflecting strong operational execution and market demand for its offerings within the industry segment, as highlighted in the sector performance metrics.
- Positive Free Cash Flow: The cash flow statements indicate a healthy free cash flow yield (freeCashFlowYieldTTM), suggesting the company generates sufficient cash to fund operations and potential investments without excessive reliance on external financing.
- Strong Current Ratio: A favorable currentRatioTTM from key metrics indicates solid liquidity, providing the company with the ability to meet short-term obligations effectively, a critical factor for financial stability.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates CLVT intrinsic value between $10.75 – $10.99 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about CLVT valuation
Is Clarivate Plc (CLVT) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Clarivate Plc (CLVT) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is CLVT a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CLVT trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is CLVT’s P/E ratio?
You can see CLVT’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for CLVT?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is CLVT a good long-term investment?
Whether CLVT fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
CLVT
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-2.46
Trading Metrics:
| Open: | 2.42 | Previous Close: | 2.44 | |
| Day Low: | 2.36 | Day High: | 2.49 | |
| Year Low: | 1.66 | Year High: | 4.77 | |
| Price Avg 50: | 2.54 | Price Avg 200: | 3.1 | |
| Volume: | 4.824M | Average Volume: | 5.131M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeCLVT full analysis
Welcome to MARKETSNAP’s SWOT analysis for Clarivate, also known by its ticker CLVT. If you’re a long-term investor looking to dig into the potential of this company, you’re in the right place. Today, we’re breaking down Clarivate, a key player in the information services and analytics space, to see what’s driving it, what’s holding it back, and where it might be headed. Let’s get straight into it with a quick overview before we dive into the nitty-gritty. Clarivate operates in…
